NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Microsoft Announces $10 Billion AI Push in Japan, Sakura Internet Stock Soars

Microsoft plans a $10 billion investment in AI and cybersecurity in Japan over 4 years. Sakura Internet stock jumps 20% as it becomes the local AI partner.

Microsoft Announces $10 Billion AI Push in Japan, Sakura Internet Stock Soars
"On April 3, 2026, Prime Minister Takaichi received a courtesy call from Mr. Brad Smith, Vice Chair and President of Microsoft."
Already have an account? Sign in.
04/03/2026 · 8:19 AM
MSFT
/ Don’t stop at just one post.

Related↓

Trump Administration Taps Oklo and X-Energy to Power AI Data Centers with Advanced Nuclear Reactors
07/21/2026 · 5:08 PM

Trump Administration Taps Oklo and X-Energy to Power AI Data Centers with Advanced Nuclear Reactors

A new federal initiative brings Oklo’s Aurora and X-Energy’s Xe-100 reactors into the spotlight as solutions to AI’s surging electricity demand.

/ Subscriber only
AMD Scores Major Win as Microsoft Adopts Helios AI Platform to Challenge Nvidia
Featured/ 07/20/2026 · 10:47 AM

Microsoft Deploys AMD Helios Racks in Azure, Boosting AMD’s Push Against Nvidia Dominance

Lower cost per token and strong TCO position AMD to gain AI market share from Nvidia.

/ Subscriber only
Starbucks Builds In-House AI Tools to Cut Reliance on Microsoft, IBM, and Oracle
Featured/ 07/09/2026 · 8:42 AM

Starbucks Builds In-House AI Tools to Cut Reliance on Microsoft, IBM, and Oracle

Starbucks aims to slash $400M in annual software spend by building its own AI tools, challenging Microsoft Dynamics, IBM TRIRIGA, and Oracle Simphony.

/ Subscriber only
/ Read more

Feed↓

Rocket Lab Secures $266 Million Suborbital Launch Contract
07/21/2026 · 6:04 PM

Rocket Lab Secures $266 Million Suborbital Launch Contract

Rocket Lab was awarded a $266M contract by the U.S. Space Systems Command for 12 suborbital missions from Alaska, with completion targeted by 2028.

/ Subscriber only
Celldex Discontinues Barzolvolimab Development in Prurigo Nodularis After Phase 2 Failure
07/21/2026 · 5:38 PM

Celldex Discontinues Barzolvolimab Development in Prurigo Nodularis After Phase 2 Failure

Celldex discontinues barzolvolimab development in prurigo nodularis after its Phase 2 study failed to meet the primary endpoint and key secondary endpoints.

/ Subscriber only
Super Micro Shocks Market with Record $60B Orders and Sharply Higher Profit Margins
Featured/ 07/21/2026 · 5:23 PM

Super Micro Shocks Market with Record $60B Orders and Sharply Higher Profit Margins

Super Micro expects gross margins nearly double previous guidance at 15-17%. Strong AI demand pushes backlog to record levels.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe